US Stock MarketDetailed Quotes

FENC Fennec Pharmaceuticals

Watchlist

5.320
+0.600+12.71%

Close Nov 22 16:00 ET

5.320
0.0000.00%

Post 20:01 ET

145.94MMarket Cap-133000P/E (TTM)

Fennec Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

20.07%-2.21M

-112.54%-8.39M

800.14%39.05M

5.07%-17.14M

28.55%-4.86M

44.91%-2.76M

-16.40%-3.95M

-95.27%-5.58M

-26.97%-18.06M

-109.61%-6.8M

Net income from continuing operations

-207.18%-5.74M

-2.00%-5.55M

312.11%12.84M

32.34%-16.05M

60.89%-2.68M

76.92%-1.87M

-7.33%-5.44M

-63.74%-6.05M

-36.71%-23.71M

-54.89%-6.86M

Depreciation and amortization

--25K

150.00%26K

1,290.38%723K

----

--0

---52K

--52K

----

Other non cash items

-57.58%336K

242.40%428K

1,990.00%418K

1.77%287K

-750.00%-650K

708.16%792K

190.70%125K

-51.22%20K

0.00%282K

-62.26%100K

Change In working capital

-9.64%-2.76M

-276.83%-4.21M

3,433.38%23.87M

-714.51%-6.78M

-160.65%-2.42M

-328.88%-2.52M

-279.45%-1.12M

-331.72%-716K

218.35%1.1M

-467.07%-930K

-Change in receivables

-101.92%-4.2M

-167.45%-2.04M

-957.97%-1.46M

-370.49%-7.27M

-177.61%-4.29M

---2.08M

---762K

---138K

---1.55M

-Change in inventory

258.86%502K

84.64%-80K

126.90%92K

-174.31%-1.58M

30.38%-401K

---316K

---521K

---342K

---576K

-Change in prepaid assets

525.24%1.31M

-40.11%109K

-1,560.31%-1.91M

-60.61%104K

14.84%-419K

-0.94%210K

-19.11%182K

-58.93%131K

211.39%264K

-348.48%-492K

-Change in payables and accrued expense

8.68%-305K

-12,147.06%-2.08M

654.50%2.04M

-33.51%1.96M

59.55%2.68M

-137.53%-334K

-104.24%-17K

-1,938.89%-367K

526.26%2.95M

566.94%1.68M

-Change in other current assets

--364K

---122K

---133K

-50.00%3K

50.00%3K

--0

400.00%6K

200.00%2K

-Change in other current liabilities

---437K

--0

--25.25M

----

--0

----

Cash from discontinued investing activities

Operating cash flow

20.07%-2.21M

-112.54%-8.39M

800.14%39.05M

5.07%-17.14M

28.55%-4.86M

44.91%-2.76M

-16.40%-3.95M

-95.27%-5.58M

-26.97%-18.06M

-109.61%-6.8M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

-362.69%-528K

-50.00%257K

-686.53%-1.13M

-67.98%6.64M

595.39%5.73M

-98.99%201K

1,017.39%514K

1,186.67%193K

316.47%20.73M

8,140.00%824K

Net issuance payments of debt

----

-74.93%5M

----

298.70%19.94M

---65K

Proceeds from stock option exercised by employees

-318.60%-470K

-35.86%347K

194.37%627K

84.91%1.72M

10.01%747K

14.36%215K

1,076.09%541K

1,320.00%213K

2,712.12%928K

7,444.44%679K

Net other financing activities

-314.29%-58K

-233.33%-90K

-8,695.00%-1.76M

42.75%-75K

-106.67%-14K

---14K

---27K

---20K

-138.18%-131K

20,900.00%210K

Cash from discontinued financing activities

Financing cash flow

-362.69%-528K

-50.00%257K

-686.53%-1.13M

-67.98%6.64M

595.39%5.73M

-98.99%201K

1,017.39%514K

1,186.67%193K

316.47%20.73M

8,140.00%824K

Net cash flow

Beginning cash position

187.83%43.05M

178.33%51.18M

-44.19%13.27M

12.67%23.77M

-58.33%12.4M

0.29%14.96M

0.72%18.39M

12.67%23.77M

-30.46%21.1M

22.26%29.75M

Current changes in cash

-6.84%-2.73M

-136.89%-8.13M

804.22%37.92M

-492.86%-10.51M

114.55%870K

-117.25%-2.56M

-2.63%-3.43M

-89.51%-5.38M

128.93%2.67M

-84.79%-5.98M

End cash Position

225.19%40.32M

187.83%43.05M

178.33%51.18M

-44.19%13.27M

-58.33%12.4M

0.29%14.96M

0.72%18.39M

12.67%23.77M

Free cash flow

20.07%-2.21M

-112.54%-8.39M

800.14%39.05M

5.07%-17.14M

28.55%-4.86M

44.91%-2.76M

-16.40%-3.95M

-95.27%-5.58M

-26.97%-18.06M

-109.61%-6.8M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	20.07%-2.21M	-112.54%-8.39M	800.14%39.05M	5.07%-17.14M	28.55%-4.86M	44.91%-2.76M	-16.40%-3.95M	-95.27%-5.58M	-26.97%-18.06M	-109.61%-6.8M
Net income from continuing operations	-207.18%-5.74M	-2.00%-5.55M	312.11%12.84M	32.34%-16.05M	60.89%-2.68M	76.92%-1.87M	-7.33%-5.44M	-63.74%-6.05M	-36.71%-23.71M	-54.89%-6.86M
Depreciation and amortization	--25K	150.00%26K	1,290.38%723K	----	----	--0	---52K	--52K	----	----
Other non cash items	-57.58%336K	242.40%428K	1,990.00%418K	1.77%287K	-750.00%-650K	708.16%792K	190.70%125K	-51.22%20K	0.00%282K	-62.26%100K
Change In working capital	-9.64%-2.76M	-276.83%-4.21M	3,433.38%23.87M	-714.51%-6.78M	-160.65%-2.42M	-328.88%-2.52M	-279.45%-1.12M	-331.72%-716K	218.35%1.1M	-467.07%-930K
-Change in receivables	-101.92%-4.2M	-167.45%-2.04M	-957.97%-1.46M	-370.49%-7.27M	-177.61%-4.29M	---2.08M	---762K	---138K	---1.55M	---1.55M
-Change in inventory	258.86%502K	84.64%-80K	126.90%92K	-174.31%-1.58M	30.38%-401K	---316K	---521K	---342K	---576K	---576K
-Change in prepaid assets	525.24%1.31M	-40.11%109K	-1,560.31%-1.91M	-60.61%104K	14.84%-419K	-0.94%210K	-19.11%182K	-58.93%131K	211.39%264K	-348.48%-492K
-Change in payables and accrued expense	8.68%-305K	-12,147.06%-2.08M	654.50%2.04M	-33.51%1.96M	59.55%2.68M	-137.53%-334K	-104.24%-17K	-1,938.89%-367K	526.26%2.95M	566.94%1.68M
-Change in other current assets	--364K	---122K	---133K	-50.00%3K	50.00%3K	--0	--0	--0	400.00%6K	200.00%2K
-Change in other current liabilities	---437K	--0	--25.25M	----	----	--0	--0	--0	----	----
Cash from discontinued investing activities
Operating cash flow	20.07%-2.21M	-112.54%-8.39M	800.14%39.05M	5.07%-17.14M	28.55%-4.86M	44.91%-2.76M	-16.40%-3.95M	-95.27%-5.58M	-26.97%-18.06M	-109.61%-6.8M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	-362.69%-528K	-50.00%257K	-686.53%-1.13M	-67.98%6.64M	595.39%5.73M	-98.99%201K	1,017.39%514K	1,186.67%193K	316.47%20.73M	8,140.00%824K
Net issuance payments of debt	----	----	----	-74.93%5M	----	----	----	----	298.70%19.94M	---65K
Proceeds from stock option exercised by employees	-318.60%-470K	-35.86%347K	194.37%627K	84.91%1.72M	10.01%747K	14.36%215K	1,076.09%541K	1,320.00%213K	2,712.12%928K	7,444.44%679K
Net other financing activities	-314.29%-58K	-233.33%-90K	-8,695.00%-1.76M	42.75%-75K	-106.67%-14K	---14K	---27K	---20K	-138.18%-131K	20,900.00%210K
Cash from discontinued financing activities
Financing cash flow	-362.69%-528K	-50.00%257K	-686.53%-1.13M	-67.98%6.64M	595.39%5.73M	-98.99%201K	1,017.39%514K	1,186.67%193K	316.47%20.73M	8,140.00%824K
Net cash flow
Beginning cash position	187.83%43.05M	178.33%51.18M	-44.19%13.27M	12.67%23.77M	-58.33%12.4M	0.29%14.96M	0.72%18.39M	12.67%23.77M	-30.46%21.1M	22.26%29.75M
Current changes in cash	-6.84%-2.73M	-136.89%-8.13M	804.22%37.92M	-492.86%-10.51M	114.55%870K	-117.25%-2.56M	-2.63%-3.43M	-89.51%-5.38M	128.93%2.67M	-84.79%-5.98M
End cash Position	225.19%40.32M	187.83%43.05M	178.33%51.18M	-44.19%13.27M	-44.19%13.27M	-58.33%12.4M	0.29%14.96M	0.72%18.39M	12.67%23.77M	12.67%23.77M
Free cash flow	20.07%-2.21M	-112.54%-8.39M	800.14%39.05M	5.07%-17.14M	28.55%-4.86M	44.91%-2.76M	-16.40%-3.95M	-95.27%-5.58M	-26.97%-18.06M	-109.61%-6.8M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data